TJHA
ARMP icon

Thomas J. Herzfeld Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7
Closed – – 310
2017
Q4 		$0 Buy
+7
New +$103 ﹤0.01% 312
2016
Q4 		– Sell
-7
Closed -$2K – 308
2016
Q3 		$2K Hold
7
– – ﹤0.01% 291
2016
Q2 		$2K Hold
7
– – ﹤0.01% 305
2016
Q1 		$4K Buy
+7
New +$3.59K ﹤0.01% 328

Other funds holding ARMP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Thomas J. Herzfeld Advisors's ARMP Position: Q1 2018 in Review

Thomas J. Herzfeld Advisors sold out of Armata Pharmaceuticals (ARMP) in Q1 2018, closing a stake of 7 shares.

Thomas J. Herzfeld Advisors first reported a position in ARMP in Q1 2016 and held it in 4 quarters. The position peaked at $4K in Q1 2016. 21 funds tracked by Wall St. Rank hold ARMP as of Q1 2018.

  • Thomas J. Herzfeld Advisors reported no remaining Armata Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Thomas J. Herzfeld Advisors sold 7 Armata Pharmaceuticals shares in Q1 2018.
  • Thomas J. Herzfeld Advisors first reported a position in Armata Pharmaceuticals in Q1 2016 and held it in 4 quarters.
  • Thomas J. Herzfeld Advisors's Armata Pharmaceuticals position peaked at $4K in Q1 2016.
  • 21 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2018.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q1 2018, filed 15 May 2018.